The ethics of creating GMO humans
By Editorial Board,
Los Angeles Times
| 08. 03. 2017
In a process that can be likened to the creation of GMO crops, scientists have edited genes in human embryos in order to eliminate a mutation that causes thickening of the heart wall. The embryos were created solely for the scientists’ study and will not be implanted. Nonetheless, the research offers hope that in years ahead, science could prevent many serious genetic diseases at the stage in which people are a microscopic cluster of cells in a petri dish. What’s more, because those edited genes would be carried forth into new generations, the disease might eventually be eliminated altogether.
Is this a glorious new frontier or a troubling situation? Unequivocally, the answer is yes to both.
The research results by an international team of U.S., Chinese and South Korean scientists were enormously exciting medically. Beyond the technical achievement involved, the team’s work hastened the arrival of a revolutionary form of treatment: removing genes that can lead inexorably to suffering and premature death.
But there is also a great deal we still don’t know about how minor issues might become major...
Related Articles
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...